Cargando…

Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has little response to immune checkpoint inhibitors. An in-depth understanding of the immune microenvironment from a comprehensive and dynamic perspective is critical to generate effective therapeutic strategies for PDAC. METHODS: Using mass cytome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jiaqi, Zhang, Qi, Wang, Junli, Lou, Yu, Hong, Zhengtao, Wei, Shumei, Sun, Ke, Wang, Jianing, Chen, Yiwen, Sheng, Jianpeng, Su, Wei, Bai, Xueli, Liang, Tingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943259/ https://www.ncbi.nlm.nih.gov/pubmed/35316682 http://dx.doi.org/10.1016/j.ebiom.2022.103958

Ejemplares similares

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
por: Tang, Tianyu, et al.
Publicado: (2021)

Multiplex imaging reveals the architecture of the tumor immune microenvironment
por: Zhang, Junlei, et al.
Publicado: (2021)

Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020)

A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma
por: Wang, Junli, et al.
Publicado: (2021)

Neoadjuvant modified-FOLFIRINOX followed by surgical resection of both the primary and metastatic tumors of a pancreatic hepatoid carcinoma with synchronous liver metastasis: A case report
por: Ma, Tao, et al.
Publicado: (2017)

Protocol for isolating single cells from human pancreatic cancer tissues and analyzing major immune cell populations using flow cytometry
por: Song, Jinyuan, et al.
Publicado: (2023)

Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy
por: Liu, Lingyue, et al.
Publicado: (2022)

Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors
por: Bai, Xueli, et al.
Publicado: (2015)

Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer
por: Wang, Meng, et al.
Publicado: (2022)

Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages
por: Chen, Qi, et al.
Publicado: (2019)

Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer
por: Zhang, Qi, et al.
Publicado: (2017)

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
por: Zhang, Xiaozhen, et al.
Publicado: (2022)

Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population
por: Li, Xiang, et al.
Publicado: (2018)

Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
por: Smith, Caitlyn, et al.
Publicado: (2022)

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Li, Ke-Yu, et al.
Publicado: (2020)

Calreticulin couples with immune checkpoints in pancreatic cancer
por: Huang, Xing, et al.
Publicado: (2020)

Glucose Metabolism: The Metabolic Signature of Tumor Associated Macrophage
por: Zhang, Qi, et al.
Publicado: (2021)

VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes
por: Shen, Yinan, et al.
Publicado: (2022)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020)

Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma
por: Lu, Qingsong, et al.
Publicado: (2023)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
por: Xu, Jiuhui, et al.
Publicado: (2023)

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
por: Yang, Hanshen, et al.
Publicado: (2022)

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing
por: Bai, Rilan, et al.
Publicado: (2022)

Eating self for not be eaten: Pancreatic cancer suppresses self-immunogenicity by autophagy-mediated MHC-I degradation
por: Huang, Xing, et al.
Publicado: (2020)

Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer
por: Fu, Qihan, et al.
Publicado: (2018)

Correction: Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer
por: Fu, Qihan, et al.
Publicado: (2019)

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020)

Sphincter of Oddi laxity alters bile duct microbiota and contributes to the recurrence of choledocholithiasis
por: Zhang, Qi, et al.
Publicado: (2020)

Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
por: Zhang, Qi, et al.
Publicado: (2019)

Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden
por: Dai, Mengyao, et al.
Publicado: (2023)

Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression
por: Wen, Liang, et al.
Publicado: (2020)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Genome‐wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis
por: Wei, Tao, et al.
Publicado: (2020)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

B7‐H5/CD28H is a co‐stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma
por: Chen, Qi, et al.
Publicado: (2019)

Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
por: Tang, Jianghui, et al.
Publicado: (2023)

Liquid biopsy in pancreatic cancer: the beginning of a new era
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

Application and Prospects of Molecular Imaging in Immunotherapy
por: Wang, Weiqing, et al.
Publicado: (2020)

Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution
por: Bai, Xueli, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jrvnl63mmir0s96m9pskve28oi